KeyBanc Trims PT On Salesforce (CRM) To $290 From $300, Reiterates “Overweight” Rating
Key takeaways
- Key Banc Trims PT On Salesforce (CRM) To $290 From $300, Reiterates “Overweight” Rating Faheem Tahir Mon, June 1, 2026 at 8:48 PM GMT+7 2 min read CRM With significant hedge fund interest, Salesforce, Inc.
- (NYSE:CRM) drew analyst attention after reporting a strong quarterly beat.
- (NYSE:CRM) reported first-quarter revenue of $11.13 billion, above the analyst estimate of $11.05 billion.
Key Banc Trims PT On Salesforce (CRM) To $290 From $300, Reiterates “Overweight” Rating Faheem Tahir Mon, June 1, 2026 at 8:48 PM GMT+7 2 min read CRM With significant hedge fund interest, Salesforce, Inc. (NYSE:CRM) secures a spot on our list of the 10 best Saa S stocks to buy according to hedge funds. As of Q1 2026, 101 hedge funds held bullish positions in the stock, representing $6.87 billion in aggregate value.
Salesforce, Inc. (NYSE:CRM) drew analyst attention after reporting a strong quarterly beat.
On May 27, 2026, Salesforce, Inc. (NYSE:CRM) reported first-quarter revenue of $11.13 billion, above the analyst estimate of $11.05 billion. Adjusted EPS came in at $3.88, well ahead of the $3.12 consensus. Subscription and support revenue grew 14%, also topping expectations. CEO Marc Benioff said the company secured 98 new deals with over $1 million in annual contract value during the quarter.